Taiho Pharmaceutical Co. Ltd.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Taiho Sends Benz LSD1 Inhibitor Fo

Promotions for Sarfez Pharmaceuticals ’ diuretic Soaanz (torsemide) make misleading efficacy claims and understate risks, the US FDA Office of Prescription Drug Promotion said in its first warning l

A promotional slide deck for Mayne Pharma ‘s Nextstellis oral contraceptive (drospirenone/estetrol) misleadingly suggests it is safer than other estrogen-containing products, the US Food and Drug Adm

Merger-and-acquisition activity in the biopharmaceutical sector had almost nowhere to go but up in the first quarter of 2025, following a historically low quarter in terms of total potential deal valu